ATE494898T1 - Zusammensetzungen mit mesenchymelen stammzellen - Google Patents

Zusammensetzungen mit mesenchymelen stammzellen

Info

Publication number
ATE494898T1
ATE494898T1 AT07014066T AT07014066T ATE494898T1 AT E494898 T1 ATE494898 T1 AT E494898T1 AT 07014066 T AT07014066 T AT 07014066T AT 07014066 T AT07014066 T AT 07014066T AT E494898 T1 ATE494898 T1 AT E494898T1
Authority
AT
Austria
Prior art keywords
mesenchymel
compositions
stem cells
stem
cells
Prior art date
Application number
AT07014066T
Other languages
English (en)
Inventor
Roger Kenneth Whealands Smith
Kenneth Gregory Mcgarrell
Allen Edward Goodship
Gordon William Blunn
Original Assignee
Quy Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0220841A external-priority patent/GB0220841D0/en
Priority claimed from GB0226275A external-priority patent/GB0226275D0/en
Application filed by Quy Biosciences Ltd filed Critical Quy Biosciences Ltd
Application granted granted Critical
Publication of ATE494898T1 publication Critical patent/ATE494898T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07014066T 2002-09-07 2003-09-08 Zusammensetzungen mit mesenchymelen stammzellen ATE494898T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0220841A GB0220841D0 (en) 2002-09-07 2002-09-07 Therapy
GB0226275A GB0226275D0 (en) 2002-11-12 2002-11-12 Method of treatment

Publications (1)

Publication Number Publication Date
ATE494898T1 true ATE494898T1 (de) 2011-01-15

Family

ID=31980022

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07014066T ATE494898T1 (de) 2002-09-07 2003-09-08 Zusammensetzungen mit mesenchymelen stammzellen
AT03793917T ATE389412T1 (de) 2002-09-07 2003-09-08 Medikament mit mesenchym-stammzellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03793917T ATE389412T1 (de) 2002-09-07 2003-09-08 Medikament mit mesenchym-stammzellen

Country Status (10)

Country Link
US (5) US8178084B2 (de)
EP (3) EP1545567B1 (de)
AR (1) AR047712A1 (de)
AT (2) ATE494898T1 (de)
AU (1) AU2003263340B2 (de)
CA (1) CA2538187C (de)
DE (2) DE60319848T2 (de)
ES (1) ES2304541T3 (de)
NZ (1) NZ539308A (de)
WO (1) WO2004022078A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
AU2004291065B2 (en) * 2003-05-13 2007-11-01 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
JP2007508018A (ja) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
WO2005065242A2 (en) 2003-12-29 2005-07-21 Am Biosolutions Method of treating cancer using platelet releasate
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
NZ580786A (en) 2007-04-24 2012-05-25 Univ Western Australia Tenocyte containing bioscaffolds and treatment using the same
US8785191B2 (en) * 2007-08-27 2014-07-22 University Of Connecticut Concentration of stem cells obtained during orthopaedic surgeries
WO2009074807A2 (en) 2007-12-12 2009-06-18 Imperial Innovations Limited Methods
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
IT1394262B1 (it) * 2008-07-17 2012-06-01 Università Degli Studi Di Milano Metodo per la produzione in vitro di tenociti a partire da cellule staminali mesenchimali, nonché rispettivi metodi per la caratterizzazione di detti tenociti e di dette cellule staminali mesenchimali
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
GB0820492D0 (en) * 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
WO2010140162A2 (en) * 2009-05-17 2010-12-09 Dravida Subhadra A process for preparing stem cell based formulations
DE102010046218A1 (de) 2010-09-21 2012-03-22 Livlmplant Gmbh Zell-basiertes Injektionssystem zur Behandlung von Verletzungen
ES2613547T3 (es) 2011-03-18 2017-05-24 Microvascular Tissues, Inc. Tejido microvascular alogénico para tratamientos de tejidos blandos
WO2014011407A2 (en) * 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
EP3476410B1 (de) 2012-09-19 2021-08-18 MicroVascular Tissues, Inc. Zusammensetzungen und verfahren zur behandlung und prävention von gewebeverletzungen und -krankheiten
US10596202B2 (en) 2012-09-19 2020-03-24 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US11819522B2 (en) 2012-09-19 2023-11-21 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US9872937B2 (en) 2012-09-19 2018-01-23 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
WO2014167142A1 (es) 2013-04-09 2014-10-16 Equicord, S.L. Procedimiento para el tratamiento de células madre mesenquimales equinas y sistema para llevar a cabo el procedimiento
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
ES2846760T3 (es) * 2013-12-19 2021-07-29 Univ Liege Células madre derivadas de músculo de mamífero
WO2016015007A1 (en) 2014-07-25 2016-01-28 Recellerate, Inc. Methods of treating exercise-induced pulmonary hemorrhage
WO2016073989A2 (en) * 2014-11-07 2016-05-12 The Trustees Of Columbia University In The City Of New York Osteochondroreticular stem cells for bone and cartilage regeneration
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2016172004A1 (en) * 2015-04-18 2016-10-27 The Johns Hopkins University Bone healing, angiogenesis-promoting and vasculogenesis-producing system
US20180318359A1 (en) * 2015-09-29 2018-11-08 Anicell Biotech, Llc Methods and articles of manufacture for the treatment of animals
US9861410B2 (en) 2016-05-06 2018-01-09 Medos International Sarl Methods, devices, and systems for blood flow
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106308817B (zh) * 2016-08-12 2023-07-28 玉溪九洲生物技术有限责任公司 一种马血浆采集***
FR3058065B1 (fr) * 2016-10-27 2019-02-01 Scarcell Therapeutics Composition pour le traitement d’une affection de l’appareil locomoteur
EP3388511A1 (de) * 2017-04-12 2018-10-17 Revatis SA Neue verwendungen von säugetiermuskelabgeleiteten stammzellen
WO2021041858A1 (en) * 2019-08-29 2021-03-04 Icahn School Of Medicine At Mount Sinai Differentiated tendon cells derived from pluripotent progenitor cells and methods of use thereof
RU2722162C1 (ru) * 2019-10-14 2020-05-27 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Способ лечения травм сухожильно-связочного аппарата у лошадей

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1996003160A1 (en) * 1994-07-26 1996-02-08 Children's Medical Center Corporation Fibrin-cell suspension for construction of new tissue
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
JP4193917B2 (ja) * 1995-12-18 2008-12-10 アンジオデバイス インターナショナル ゲーエムベーハー 架橋ポリマー組成物およびその使用方法
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US6280473B1 (en) * 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
EP2110431A1 (de) * 1997-05-13 2009-10-21 Osiris Therapeutics, Inc. Knorpelregeneration unter Verwendung menschlicher mesenchymaler Stammzellen
JP4562816B2 (ja) 1997-07-14 2010-10-13 オシリス セラピューティクス，インコーポレイテッド 心筋再生のための間葉幹細胞の使用法および組成物
US20020123143A1 (en) * 1997-08-22 2002-09-05 Jean Toma Multipotent stem cells from peripheral tissues and uses thereof
WO1999046366A1 (en) * 1998-03-13 1999-09-16 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
US6835377B2 (en) * 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
DE69937888T2 (de) * 1998-07-31 2009-01-02 Genzyme Corp., Cambridge Verfahren zur Herstellung mesenchymaler Stammzellen
WO2000049136A1 (en) * 1999-02-17 2000-08-24 United States Surgical Genetically altered mesenchymal stem cells and methods of use thereof
FR2799371A1 (fr) * 1999-10-12 2001-04-13 Univ Paris Curie Compositions de tenocytes preparation et utilisations
EP1099754A1 (de) 1999-11-10 2001-05-16 Universiteit Leiden Mesenchym-Stammzellen und/oder Vorlaüferzellen, ihre Isolierung und ihre Verwendung
EP2283880A3 (de) 2000-03-20 2014-07-09 Biosphere Medical, Inc. Injizierbare Mikrokügelchen für den Gewebeaufbau
AU2001257236B2 (en) 2000-04-25 2006-03-09 Mesoblast International Sarl Joint repair using mesenchymal stem cells
US20020045260A1 (en) * 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
WO2002034889A2 (en) * 2000-10-24 2002-05-02 Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
WO2003015802A1 (en) 2001-08-14 2003-02-27 Medipost, Co., Ltd. Composition for treatment of articular cartilage damage
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair

Also Published As

Publication number Publication date
US8178084B2 (en) 2012-05-15
CA2538187A1 (en) 2004-03-18
US20170258848A1 (en) 2017-09-14
US20130039896A1 (en) 2013-02-14
EP1545567A1 (de) 2005-06-29
US20150017145A1 (en) 2015-01-15
ATE389412T1 (de) 2008-04-15
CA2538187C (en) 2019-01-08
WO2004022078A1 (en) 2004-03-18
ES2304541T3 (es) 2008-10-16
DE60319848T2 (de) 2009-04-30
AU2003263340B2 (en) 2008-12-18
EP1545567B1 (de) 2008-03-19
EP1872789A1 (de) 2008-01-02
US20120230960A1 (en) 2012-09-13
NZ539308A (en) 2008-03-28
DE60335752D1 (de) 2011-02-24
DE60319848D1 (de) 2008-04-30
EP2316462A1 (de) 2011-05-04
AR047712A1 (es) 2006-02-15
AU2003263340A1 (en) 2004-03-29
EP1872789B1 (de) 2011-01-12
US20060130852A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
ATE494898T1 (de) Zusammensetzungen mit mesenchymelen stammzellen
DE10324396A8 (de) Brennstoffzelle
DE10393374D2 (de) Zusammensetzung
GB2407821B (en) Stem Cells
GB0329449D0 (en) Stem cells
AU2003247514A8 (en) Meningeal-derived stem cells
DE60335716D1 (de) Beschleuniger-zusammensetzung
SE0500163L (sv) Sammansättning
DE60329024D1 (de) Brennstoffzelle
DE60333528D1 (de) Elektrolytzusammensetzungen
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DE60303345D1 (de) Brennstoffzelle
DE60329174D1 (de) Mehrwegventil
DE60332389D1 (de) Monocyclopentadienylkomplexe
DE60323022D1 (de) Brennstoffzelle
DK1548110T3 (da) Transglutaminase-producerende stamme
DK1335130T3 (da) Darrieus-vindmölle
DE502004008433D1 (de) Wägezelle
ATE504290T1 (de) Zusammensetzungen mit neramexan
DE50303362D1 (de) Kraftaufnehmer
DE50303404D1 (de) Rückflussverhinderer
DE50302820D1 (de) Kraftaufnehmer
NO20044140D0 (no) New Composition
DE60303959D1 (de) Monocyclopentadienylkomplexe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties